Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.

Miller JD, Lenhart GM, Bonafede MM, Lukes AS, Laughlin-Tommaso SK.

Popul Health Manag. 2015 Oct;18(5):373-82. doi: 10.1089/pop.2014.0148. Epub 2015 Feb 25.

2.

Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.

Lisotto C, Guidotti M, Zava D, Savi L.

J Headache Pain. 2013 Dec 11;14:96. doi: 10.1186/1129-2377-14-96.

3.

CGRP and migraine: could PACAP play a role too?

Kaiser EA, Russo AF.

Neuropeptides. 2013 Dec;47(6):451-61. doi: 10.1016/j.npep.2013.10.010. Epub 2013 Oct 23. Review.

4.

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study.

Wang L, Wei W, Miao R, Xie L, Baser O.

BMJ Open. 2013 Apr 30;3(4). pii: e002348. doi: 10.1136/bmjopen-2012-002348. Print 2013.

5.

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.

Polsky D, Bonafede M, Suaya JA.

BMC Health Serv Res. 2012 Oct 31;12:379. doi: 10.1186/1472-6963-12-379.

6.

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine.

Vikelis M, Mitsikostas DD, Rapoport AM.

Neuropsychiatr Dis Treat. 2012;8:429-34. doi: 10.2147/NDT.S27456. Epub 2012 Sep 26.

7.

The role of funding and policies on innovation in cancer drug development.

Kanavos P, Sullivan R, Lewison G, Schurer W, Eckhouse S, Vlachopioti Z.

Ecancermedicalscience. 2010;4:164. doi: 10.3332/ecancer.2010.164. Epub 2010 Feb 3. No abstract available.

8.

A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns.

Muzina DJ, Chen W, Bowlin SJ.

Neuropsychiatr Dis Treat. 2011;7:663-72. doi: 10.2147/NDT.S25463. Epub 2011 Nov 11.

9.

Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis.

Hodgkins P, Montejano L, Sasané R, Huse D.

Prim Care Companion CNS Disord. 2011;13(2). pii: PCC.10m01031. doi: 10.4088/PCC.10m01031.

10.

Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis.

Hodgkins P, Montejano L, Sasané R, Huse D.

Prim Care Companion CNS Disord. 2011;13(2). pii: PCC.10m01030. doi: 10.4088/PCC.10m01030.

11.

The associations of migraines and other headaches with work performance: results from the National Comorbidity Survey Replication (NCS-R).

Kessler RC, Shahly V, Stang PE, Lane MC.

Cephalalgia. 2010 Jun;30(6):722-34. doi: 10.1177/0333102410363766. Epub 2010 Mar 26.

12.

Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.

Buse DC, Rupnow MF, Lipton RB.

Mayo Clin Proc. 2009 May;84(5):422-35. doi: 10.1016/S0025-6196(11)60561-2. Review.

13.

Are migraineur women really more vulnerable to stress and less able to cope?

Gunel MK, Akkaya FY.

BMC Health Serv Res. 2008 Oct 10;8:211. doi: 10.1186/1472-6963-8-211.

14.

Improving care through health economics analyses: cost of illness and headache.

Mennini FS, Gitto L, Martelletti P.

J Headache Pain. 2008 Aug;9(4):199-206. doi: 10.1007/s10194-008-0051-9. Epub 2008 Jul 5. Review.

Supplemental Content

Support Center